Abstract
There has been a dramatic increase in the incidence of diabetes worldwide,
which has been exacerbated by the growing obesity problem across the globe.
Once thought of as primarily a childhood disease--sometimes referred to as
juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to
the adoption of a high-fat, high-carbohydrate, high-calorie American diet has
resulted in skyrocketing rates of diabetes among adults across the world. To
compound the global diabetes epidemic, health professionals are witnessing an
alarming increase in inflammatory diseases resulting from adult onset (i.e.,
Type 2) diabetes. This phenomenon is referred to as “metabolic
syndrome” where a confluence of inflammatory conditions occur along with
the diabetes. As a result, growing evidence appears to show that metabolic
syndrome makes the diabetic patient susceptible to degenerative health
conditions such as cardiovascular disease, stroke and, now believed,
Alzheimer' s disease. As the diabetes epidemic escalates, a new sense of
urgency has taken hold. Proactive strategies for prevention of the disease are
being put in place by international health organizations such as the World
Health Organization (WHO), as well as by the health departments of
industrialized and developing countries, and even at the local level where
food ingredients regulations are being passed. This TriMark Publications
report charts the changing landscape of the global diabetic population and
explores the added health concerns resulting from the metabolic syndrome
phenomenon and one of its major risk factors: cardiovascular disease
(CVD). Furthermore, this study evaluates widely-accepted therapeutic
approaches to diabetes that are currently in use, while providing an in-depth
analysis of emerging technologies that will be used to treat diabetes and
other inflammatory diseases in the future.
Report Statistics:- Pages: 265
- Format: PDF document
| 
View Cart
